Linked Data API

Show Search Form

Search Results

536471
registered interest false more like this
date remove filter
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Antimicrobials: Drug Resistance more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what role he plans for the UK in discussing antimicrobial resistance at the G20 summit in September 2016. more like this
tabling member constituency Thirsk and Malton remove filter
tabling member printed
Kevin Hollinrake more like this
uin 42800 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2016-07-19more like thismore than 2016-07-19
answer text <p>Antimicrobial resistance (AMR) is growing, presenting huge costs to both society and the global economy – it is estimated that AMR will have a cumulative cost of $100 trillion by 2050. One of the main issues driving the increase in AMR is a market failure preventing enough new antibiotic drugs from getting to market. The United Kingdom sees the G20 as the best forum to discuss this economic issue and take action. The UK is calling for the G20 to look at how it can put in place innovative financing mechanisms to reinvigorate the antimicrobial development pipeline and help rectify this market failure.</p> more like this
answering member constituency Oxford West and Abingdon more like this
answering member printed Nicola Blackwood more like this
question first answered
less than 2016-07-19T13:46:45.8Zmore like thismore than 2016-07-19T13:46:45.8Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
4474
label Biography information for Kevin Hollinrake more like this